Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures

Completed · Phase 3

Conditions studied: Partial Epilepsies, Partial Onset Seizures

In brief

The purpose of this study is to allow eligible subjects from the parent study, SP925 \[NCT00655551\] to continue lacosamide and to obtain additional long-term safety data

Key facts

Study ID

NCT00655486

Run by

UCB BIOSCIENCES, Inc.

People needed

97

Starts

2008-04-01

Expected to finish

2010-06-01

Last updated by the study team

2018-07-17

Who can join

Age: 16 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Eligible subjects who participated in SP925 [NCT00655551] for treatment of partial-onset seizures

You may not qualify if…

• Receiving any study drug or experimental device other than lacosamide
• Meets withdrawal criteria for parent study SP925 [NCT00655551]
• Experiencing ongoing serious adverse event

Where it is running

• Study site — Phoenix, Arizona, United States
• Study site — Baltimore, Maryland, United States
• Study site — Chesterfield, Missouri, United States
• Study site — Columbus, Ohio, United States
• Study site — Philadelphia, Pennsylvania, United States
• Study site — Dallas, Texas, United States
• Study site — Charlottesville, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.